International Journal of Medical Sciences-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2138227, encodeId=fa1c213822ef2, content=请问这个杂志审稿分几个状态？现在状态是under review，是已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74fc8710249, createdName=ms5000000086594818, createdTime=Sun May 21 20:06:58 CST 2023, time=2023-05-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2118366, encodeId=37bb211836614, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生物标志物;biomarker 经验分享：Received 2023-1-6 Minor revision 2023-3-4 Final accept 2023-3-9 综述文章，审稿人很友好 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIQMh5jMlvAibkVyDXOqwvbsicXibGz4JKG4vvKy81kYq8jSFxGOWAlFqFMWvbOFqt64ibxIUWFTicLeCw/132, createdBy=c12c1661090, createdName=m414297222, createdTime=Thu Mar 09 00:21:48 CST 2023, time=2023-03-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2113050, encodeId=4bbd2113050f5, content=大家最近有投稿吗？多久给回复呢，已经一个月了还在审稿中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Sat Feb 04 21:00:44 CST 2023, time=2023-02-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2094070, encodeId=b7d720940e0cb, content=投了之后多久才会改变状态啊，已经投了一个星期了，还是received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72028228946, createdName=ms4000001076782729, createdTime=Sun Oct 16 16:32:02 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102810, encodeId=bedc21028102f, content=有人有这个期刊的word模板么？能不能发我一下，求助，官网没看到。谢谢了。1225470737*******, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1828451162, createdName=ms6000000080545536, createdTime=Sat Nov 26 21:07:13 CST 2022, time=2022-11-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2091929, encodeId=505020919297d, content=请问下该杂志对创新要求高吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72028228946, createdName=ms4000001076782729, createdTime=Wed Oct 05 16:52:36 CST 2022, time=2022-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081263, encodeId=7c541081263ee, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：Received 2021-9-12 Major revision 2021-10-27 Minor revision 2021-12-12 Final accept 2021-12-16 感觉总体来说找到合适的审稿人之后速度还是比较快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d625572154, createdName=wuyan0120, createdTime=Fri Dec 17 20:24:46 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897587, encodeId=a72289e58732, content=审稿4个月，催了三次，最好使用注册时候那个机构邮箱催稿。编辑说很感兴趣，有两个审稿人给了意见，第一个审稿人就夸了夸，第二个人审稿人夸了又给了两条意见。既然夸了就让我过吧求求了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/bc1839eb835e4a28b43c88ba0fd6023b/c54dc7c370634275b2efa25e2af54d04.jpg, createdBy=39735206960, createdName=小汤圆有小心脏, createdTime=Sat Nov 07 17:13:32 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240556, encodeId=cc5212405566a, content=偏重的研究方向：肝癌 经验分享：这个期刊官网上写SCIE Web of science上又写着SCI核心收录，到底算不算核心呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0e08209194, createdName=ms9000002127937775, createdTime=Tue Aug 23 17:49:27 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509261, encodeId=e9f550926139, content=18号刚投出去，期待有个好结果。这个杂志有2个特殊要求：1是要提供官方的邮箱，如edu.cn为结尾的邮箱；2是最好推介不少于3个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcb798907, createdName=bowen, createdTime=Tue Jan 20 21:07:00 CST 2015, time=2015-01-20, status=1, ipAttribution=)]

2023-05-21 ms5000000086594818 来自上海

请问这个杂志审稿分几个状态？现在状态是under review，是已经送审了吗？

25 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2138227, encodeId=fa1c213822ef2, content=请问这个杂志审稿分几个状态？现在状态是under review，是已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74fc8710249, createdName=ms5000000086594818, createdTime=Sun May 21 20:06:58 CST 2023, time=2023-05-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2118366, encodeId=37bb211836614, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生物标志物;biomarker 经验分享：Received 2023-1-6 Minor revision 2023-3-4 Final accept 2023-3-9 综述文章，审稿人很友好 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIQMh5jMlvAibkVyDXOqwvbsicXibGz4JKG4vvKy81kYq8jSFxGOWAlFqFMWvbOFqt64ibxIUWFTicLeCw/132, createdBy=c12c1661090, createdName=m414297222, createdTime=Thu Mar 09 00:21:48 CST 2023, time=2023-03-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2113050, encodeId=4bbd2113050f5, content=大家最近有投稿吗？多久给回复呢，已经一个月了还在审稿中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Sat Feb 04 21:00:44 CST 2023, time=2023-02-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2094070, encodeId=b7d720940e0cb, content=投了之后多久才会改变状态啊，已经投了一个星期了，还是received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72028228946, createdName=ms4000001076782729, createdTime=Sun Oct 16 16:32:02 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102810, encodeId=bedc21028102f, content=有人有这个期刊的word模板么？能不能发我一下，求助，官网没看到。谢谢了。1225470737*******, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1828451162, createdName=ms6000000080545536, createdTime=Sat Nov 26 21:07:13 CST 2022, time=2022-11-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2091929, encodeId=505020919297d, content=请问下该杂志对创新要求高吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72028228946, createdName=ms4000001076782729, createdTime=Wed Oct 05 16:52:36 CST 2022, time=2022-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081263, encodeId=7c541081263ee, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：Received 2021-9-12 Major revision 2021-10-27 Minor revision 2021-12-12 Final accept 2021-12-16 感觉总体来说找到合适的审稿人之后速度还是比较快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d625572154, createdName=wuyan0120, createdTime=Fri Dec 17 20:24:46 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897587, encodeId=a72289e58732, content=审稿4个月，催了三次，最好使用注册时候那个机构邮箱催稿。编辑说很感兴趣，有两个审稿人给了意见，第一个审稿人就夸了夸，第二个人审稿人夸了又给了两条意见。既然夸了就让我过吧求求了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/bc1839eb835e4a28b43c88ba0fd6023b/c54dc7c370634275b2efa25e2af54d04.jpg, createdBy=39735206960, createdName=小汤圆有小心脏, createdTime=Sat Nov 07 17:13:32 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240556, encodeId=cc5212405566a, content=偏重的研究方向：肝癌 经验分享：这个期刊官网上写SCIE Web of science上又写着SCI核心收录，到底算不算核心呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0e08209194, createdName=ms9000002127937775, createdTime=Tue Aug 23 17:49:27 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509261, encodeId=e9f550926139, content=18号刚投出去，期待有个好结果。这个杂志有2个特殊要求：1是要提供官方的邮箱，如edu.cn为结尾的邮箱；2是最好推介不少于3个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcb798907, createdName=bowen, createdTime=Tue Jan 20 21:07:00 CST 2015, time=2015-01-20, status=1, ipAttribution=)]

2023-03-09 m414297222 来自辽宁省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤;生物标志物;biomarker
经验分享：Received 2023-1-6 Minor revision 2023-3-4 Final accept 2023-3-9 综述文章，审稿人很友好

47 0

[GetPortalCommentsPageByObjectIdResponse(id=2138227, encodeId=fa1c213822ef2, content=请问这个杂志审稿分几个状态？现在状态是under review，是已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74fc8710249, createdName=ms5000000086594818, createdTime=Sun May 21 20:06:58 CST 2023, time=2023-05-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2118366, encodeId=37bb211836614, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生物标志物;biomarker 经验分享：Received 2023-1-6 Minor revision 2023-3-4 Final accept 2023-3-9 综述文章，审稿人很友好 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIQMh5jMlvAibkVyDXOqwvbsicXibGz4JKG4vvKy81kYq8jSFxGOWAlFqFMWvbOFqt64ibxIUWFTicLeCw/132, createdBy=c12c1661090, createdName=m414297222, createdTime=Thu Mar 09 00:21:48 CST 2023, time=2023-03-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2113050, encodeId=4bbd2113050f5, content=大家最近有投稿吗？多久给回复呢，已经一个月了还在审稿中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Sat Feb 04 21:00:44 CST 2023, time=2023-02-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2094070, encodeId=b7d720940e0cb, content=投了之后多久才会改变状态啊，已经投了一个星期了，还是received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72028228946, createdName=ms4000001076782729, createdTime=Sun Oct 16 16:32:02 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102810, encodeId=bedc21028102f, content=有人有这个期刊的word模板么？能不能发我一下，求助，官网没看到。谢谢了。1225470737*******, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1828451162, createdName=ms6000000080545536, createdTime=Sat Nov 26 21:07:13 CST 2022, time=2022-11-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2091929, encodeId=505020919297d, content=请问下该杂志对创新要求高吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72028228946, createdName=ms4000001076782729, createdTime=Wed Oct 05 16:52:36 CST 2022, time=2022-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081263, encodeId=7c541081263ee, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：Received 2021-9-12 Major revision 2021-10-27 Minor revision 2021-12-12 Final accept 2021-12-16 感觉总体来说找到合适的审稿人之后速度还是比较快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d625572154, createdName=wuyan0120, createdTime=Fri Dec 17 20:24:46 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897587, encodeId=a72289e58732, content=审稿4个月，催了三次，最好使用注册时候那个机构邮箱催稿。编辑说很感兴趣，有两个审稿人给了意见，第一个审稿人就夸了夸，第二个人审稿人夸了又给了两条意见。既然夸了就让我过吧求求了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/bc1839eb835e4a28b43c88ba0fd6023b/c54dc7c370634275b2efa25e2af54d04.jpg, createdBy=39735206960, createdName=小汤圆有小心脏, createdTime=Sat Nov 07 17:13:32 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240556, encodeId=cc5212405566a, content=偏重的研究方向：肝癌 经验分享：这个期刊官网上写SCIE Web of science上又写着SCI核心收录，到底算不算核心呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0e08209194, createdName=ms9000002127937775, createdTime=Tue Aug 23 17:49:27 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509261, encodeId=e9f550926139, content=18号刚投出去，期待有个好结果。这个杂志有2个特殊要求：1是要提供官方的邮箱，如edu.cn为结尾的邮箱；2是最好推介不少于3个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcb798907, createdName=bowen, createdTime=Tue Jan 20 21:07:00 CST 2015, time=2015-01-20, status=1, ipAttribution=)]

2023-02-04 ms4000001065776869 来自北京

大家最近有投稿吗？多久给回复呢，已经一个月了还在审稿中

37 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2138227, encodeId=fa1c213822ef2, content=请问这个杂志审稿分几个状态？现在状态是under review，是已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74fc8710249, createdName=ms5000000086594818, createdTime=Sun May 21 20:06:58 CST 2023, time=2023-05-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2118366, encodeId=37bb211836614, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生物标志物;biomarker 经验分享：Received 2023-1-6 Minor revision 2023-3-4 Final accept 2023-3-9 综述文章，审稿人很友好 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIQMh5jMlvAibkVyDXOqwvbsicXibGz4JKG4vvKy81kYq8jSFxGOWAlFqFMWvbOFqt64ibxIUWFTicLeCw/132, createdBy=c12c1661090, createdName=m414297222, createdTime=Thu Mar 09 00:21:48 CST 2023, time=2023-03-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2113050, encodeId=4bbd2113050f5, content=大家最近有投稿吗？多久给回复呢，已经一个月了还在审稿中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Sat Feb 04 21:00:44 CST 2023, time=2023-02-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2094070, encodeId=b7d720940e0cb, content=投了之后多久才会改变状态啊，已经投了一个星期了，还是received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72028228946, createdName=ms4000001076782729, createdTime=Sun Oct 16 16:32:02 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102810, encodeId=bedc21028102f, content=有人有这个期刊的word模板么？能不能发我一下，求助，官网没看到。谢谢了。1225470737*******, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1828451162, createdName=ms6000000080545536, createdTime=Sat Nov 26 21:07:13 CST 2022, time=2022-11-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2091929, encodeId=505020919297d, content=请问下该杂志对创新要求高吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72028228946, createdName=ms4000001076782729, createdTime=Wed Oct 05 16:52:36 CST 2022, time=2022-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081263, encodeId=7c541081263ee, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：Received 2021-9-12 Major revision 2021-10-27 Minor revision 2021-12-12 Final accept 2021-12-16 感觉总体来说找到合适的审稿人之后速度还是比较快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d625572154, createdName=wuyan0120, createdTime=Fri Dec 17 20:24:46 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897587, encodeId=a72289e58732, content=审稿4个月，催了三次，最好使用注册时候那个机构邮箱催稿。编辑说很感兴趣，有两个审稿人给了意见，第一个审稿人就夸了夸，第二个人审稿人夸了又给了两条意见。既然夸了就让我过吧求求了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/bc1839eb835e4a28b43c88ba0fd6023b/c54dc7c370634275b2efa25e2af54d04.jpg, createdBy=39735206960, createdName=小汤圆有小心脏, createdTime=Sat Nov 07 17:13:32 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240556, encodeId=cc5212405566a, content=偏重的研究方向：肝癌 经验分享：这个期刊官网上写SCIE Web of science上又写着SCI核心收录，到底算不算核心呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0e08209194, createdName=ms9000002127937775, createdTime=Tue Aug 23 17:49:27 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509261, encodeId=e9f550926139, content=18号刚投出去，期待有个好结果。这个杂志有2个特殊要求：1是要提供官方的邮箱，如edu.cn为结尾的邮箱；2是最好推介不少于3个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcb798907, createdName=bowen, createdTime=Tue Jan 20 21:07:00 CST 2015, time=2015-01-20, status=1, ipAttribution=)]

2022-10-16 ms4000001076782729

投了之后多久才会改变状态啊，已经投了一个星期了，还是received

48 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2138227, encodeId=fa1c213822ef2, content=请问这个杂志审稿分几个状态？现在状态是under review，是已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74fc8710249, createdName=ms5000000086594818, createdTime=Sun May 21 20:06:58 CST 2023, time=2023-05-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2118366, encodeId=37bb211836614, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生物标志物;biomarker 经验分享：Received 2023-1-6 Minor revision 2023-3-4 Final accept 2023-3-9 综述文章，审稿人很友好 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIQMh5jMlvAibkVyDXOqwvbsicXibGz4JKG4vvKy81kYq8jSFxGOWAlFqFMWvbOFqt64ibxIUWFTicLeCw/132, createdBy=c12c1661090, createdName=m414297222, createdTime=Thu Mar 09 00:21:48 CST 2023, time=2023-03-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2113050, encodeId=4bbd2113050f5, content=大家最近有投稿吗？多久给回复呢，已经一个月了还在审稿中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Sat Feb 04 21:00:44 CST 2023, time=2023-02-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2094070, encodeId=b7d720940e0cb, content=投了之后多久才会改变状态啊，已经投了一个星期了，还是received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72028228946, createdName=ms4000001076782729, createdTime=Sun Oct 16 16:32:02 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102810, encodeId=bedc21028102f, content=有人有这个期刊的word模板么？能不能发我一下，求助，官网没看到。谢谢了。1225470737*******, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1828451162, createdName=ms6000000080545536, createdTime=Sat Nov 26 21:07:13 CST 2022, time=2022-11-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2091929, encodeId=505020919297d, content=请问下该杂志对创新要求高吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72028228946, createdName=ms4000001076782729, createdTime=Wed Oct 05 16:52:36 CST 2022, time=2022-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081263, encodeId=7c541081263ee, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：Received 2021-9-12 Major revision 2021-10-27 Minor revision 2021-12-12 Final accept 2021-12-16 感觉总体来说找到合适的审稿人之后速度还是比较快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d625572154, createdName=wuyan0120, createdTime=Fri Dec 17 20:24:46 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897587, encodeId=a72289e58732, content=审稿4个月，催了三次，最好使用注册时候那个机构邮箱催稿。编辑说很感兴趣，有两个审稿人给了意见，第一个审稿人就夸了夸，第二个人审稿人夸了又给了两条意见。既然夸了就让我过吧求求了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/bc1839eb835e4a28b43c88ba0fd6023b/c54dc7c370634275b2efa25e2af54d04.jpg, createdBy=39735206960, createdName=小汤圆有小心脏, createdTime=Sat Nov 07 17:13:32 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240556, encodeId=cc5212405566a, content=偏重的研究方向：肝癌 经验分享：这个期刊官网上写SCIE Web of science上又写着SCI核心收录，到底算不算核心呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0e08209194, createdName=ms9000002127937775, createdTime=Tue Aug 23 17:49:27 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509261, encodeId=e9f550926139, content=18号刚投出去，期待有个好结果。这个杂志有2个特殊要求：1是要提供官方的邮箱，如edu.cn为结尾的邮箱；2是最好推介不少于3个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcb798907, createdName=bowen, createdTime=Tue Jan 20 21:07:00 CST 2015, time=2015-01-20, status=1, ipAttribution=)]

2022-11-26 ms6000000080545536 来自湖南省

有人有这个期刊的word模板么？能不能发我一下，求助，官网没看到。谢谢了。1225470737*******

35 0

[GetPortalCommentsPageByObjectIdResponse(id=2138227, encodeId=fa1c213822ef2, content=请问这个杂志审稿分几个状态？现在状态是under review，是已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74fc8710249, createdName=ms5000000086594818, createdTime=Sun May 21 20:06:58 CST 2023, time=2023-05-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2118366, encodeId=37bb211836614, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生物标志物;biomarker 经验分享：Received 2023-1-6 Minor revision 2023-3-4 Final accept 2023-3-9 综述文章，审稿人很友好 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIQMh5jMlvAibkVyDXOqwvbsicXibGz4JKG4vvKy81kYq8jSFxGOWAlFqFMWvbOFqt64ibxIUWFTicLeCw/132, createdBy=c12c1661090, createdName=m414297222, createdTime=Thu Mar 09 00:21:48 CST 2023, time=2023-03-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2113050, encodeId=4bbd2113050f5, content=大家最近有投稿吗？多久给回复呢，已经一个月了还在审稿中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Sat Feb 04 21:00:44 CST 2023, time=2023-02-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2094070, encodeId=b7d720940e0cb, content=投了之后多久才会改变状态啊，已经投了一个星期了，还是received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72028228946, createdName=ms4000001076782729, createdTime=Sun Oct 16 16:32:02 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102810, encodeId=bedc21028102f, content=有人有这个期刊的word模板么？能不能发我一下，求助，官网没看到。谢谢了。1225470737*******, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1828451162, createdName=ms6000000080545536, createdTime=Sat Nov 26 21:07:13 CST 2022, time=2022-11-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2091929, encodeId=505020919297d, content=请问下该杂志对创新要求高吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72028228946, createdName=ms4000001076782729, createdTime=Wed Oct 05 16:52:36 CST 2022, time=2022-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081263, encodeId=7c541081263ee, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：Received 2021-9-12 Major revision 2021-10-27 Minor revision 2021-12-12 Final accept 2021-12-16 感觉总体来说找到合适的审稿人之后速度还是比较快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d625572154, createdName=wuyan0120, createdTime=Fri Dec 17 20:24:46 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897587, encodeId=a72289e58732, content=审稿4个月，催了三次，最好使用注册时候那个机构邮箱催稿。编辑说很感兴趣，有两个审稿人给了意见，第一个审稿人就夸了夸，第二个人审稿人夸了又给了两条意见。既然夸了就让我过吧求求了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/bc1839eb835e4a28b43c88ba0fd6023b/c54dc7c370634275b2efa25e2af54d04.jpg, createdBy=39735206960, createdName=小汤圆有小心脏, createdTime=Sat Nov 07 17:13:32 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240556, encodeId=cc5212405566a, content=偏重的研究方向：肝癌 经验分享：这个期刊官网上写SCIE Web of science上又写着SCI核心收录，到底算不算核心呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0e08209194, createdName=ms9000002127937775, createdTime=Tue Aug 23 17:49:27 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509261, encodeId=e9f550926139, content=18号刚投出去，期待有个好结果。这个杂志有2个特殊要求：1是要提供官方的邮箱，如edu.cn为结尾的邮箱；2是最好推介不少于3个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcb798907, createdName=bowen, createdTime=Tue Jan 20 21:07:00 CST 2015, time=2015-01-20, status=1, ipAttribution=)]

2022-10-05 ms4000001076782729

请问下该杂志对创新要求高吗

49 0

[GetPortalCommentsPageByObjectIdResponse(id=2138227, encodeId=fa1c213822ef2, content=请问这个杂志审稿分几个状态？现在状态是under review，是已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74fc8710249, createdName=ms5000000086594818, createdTime=Sun May 21 20:06:58 CST 2023, time=2023-05-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2118366, encodeId=37bb211836614, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生物标志物;biomarker 经验分享：Received 2023-1-6 Minor revision 2023-3-4 Final accept 2023-3-9 综述文章，审稿人很友好 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIQMh5jMlvAibkVyDXOqwvbsicXibGz4JKG4vvKy81kYq8jSFxGOWAlFqFMWvbOFqt64ibxIUWFTicLeCw/132, createdBy=c12c1661090, createdName=m414297222, createdTime=Thu Mar 09 00:21:48 CST 2023, time=2023-03-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2113050, encodeId=4bbd2113050f5, content=大家最近有投稿吗？多久给回复呢，已经一个月了还在审稿中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Sat Feb 04 21:00:44 CST 2023, time=2023-02-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2094070, encodeId=b7d720940e0cb, content=投了之后多久才会改变状态啊，已经投了一个星期了，还是received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72028228946, createdName=ms4000001076782729, createdTime=Sun Oct 16 16:32:02 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102810, encodeId=bedc21028102f, content=有人有这个期刊的word模板么？能不能发我一下，求助，官网没看到。谢谢了。1225470737*******, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1828451162, createdName=ms6000000080545536, createdTime=Sat Nov 26 21:07:13 CST 2022, time=2022-11-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2091929, encodeId=505020919297d, content=请问下该杂志对创新要求高吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72028228946, createdName=ms4000001076782729, createdTime=Wed Oct 05 16:52:36 CST 2022, time=2022-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081263, encodeId=7c541081263ee, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：Received 2021-9-12 Major revision 2021-10-27 Minor revision 2021-12-12 Final accept 2021-12-16 感觉总体来说找到合适的审稿人之后速度还是比较快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d625572154, createdName=wuyan0120, createdTime=Fri Dec 17 20:24:46 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897587, encodeId=a72289e58732, content=审稿4个月，催了三次，最好使用注册时候那个机构邮箱催稿。编辑说很感兴趣，有两个审稿人给了意见，第一个审稿人就夸了夸，第二个人审稿人夸了又给了两条意见。既然夸了就让我过吧求求了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/bc1839eb835e4a28b43c88ba0fd6023b/c54dc7c370634275b2efa25e2af54d04.jpg, createdBy=39735206960, createdName=小汤圆有小心脏, createdTime=Sat Nov 07 17:13:32 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240556, encodeId=cc5212405566a, content=偏重的研究方向：肝癌 经验分享：这个期刊官网上写SCIE Web of science上又写着SCI核心收录，到底算不算核心呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0e08209194, createdName=ms9000002127937775, createdTime=Tue Aug 23 17:49:27 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509261, encodeId=e9f550926139, content=18号刚投出去，期待有个好结果。这个杂志有2个特殊要求：1是要提供官方的邮箱，如edu.cn为结尾的邮箱；2是最好推介不少于3个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcb798907, createdName=bowen, createdTime=Tue Jan 20 21:07:00 CST 2015, time=2015-01-20, status=1, ipAttribution=)]

2021-12-17 wuyan0120

审稿速度:3.0
偏重的研究方向：肿瘤
经验分享：Received 2021-9-12
Major revision 2021-10-27
Minor revision 2021-12-12
Final accept 2021-12-16
感觉总体来说找到合适的审稿人之后速度还是比较快的。

74 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2138227, encodeId=fa1c213822ef2, content=请问这个杂志审稿分几个状态？现在状态是under review，是已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74fc8710249, createdName=ms5000000086594818, createdTime=Sun May 21 20:06:58 CST 2023, time=2023-05-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2118366, encodeId=37bb211836614, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生物标志物;biomarker 经验分享：Received 2023-1-6 Minor revision 2023-3-4 Final accept 2023-3-9 综述文章，审稿人很友好 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIQMh5jMlvAibkVyDXOqwvbsicXibGz4JKG4vvKy81kYq8jSFxGOWAlFqFMWvbOFqt64ibxIUWFTicLeCw/132, createdBy=c12c1661090, createdName=m414297222, createdTime=Thu Mar 09 00:21:48 CST 2023, time=2023-03-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2113050, encodeId=4bbd2113050f5, content=大家最近有投稿吗？多久给回复呢，已经一个月了还在审稿中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Sat Feb 04 21:00:44 CST 2023, time=2023-02-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2094070, encodeId=b7d720940e0cb, content=投了之后多久才会改变状态啊，已经投了一个星期了，还是received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72028228946, createdName=ms4000001076782729, createdTime=Sun Oct 16 16:32:02 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102810, encodeId=bedc21028102f, content=有人有这个期刊的word模板么？能不能发我一下，求助，官网没看到。谢谢了。1225470737*******, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1828451162, createdName=ms6000000080545536, createdTime=Sat Nov 26 21:07:13 CST 2022, time=2022-11-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2091929, encodeId=505020919297d, content=请问下该杂志对创新要求高吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72028228946, createdName=ms4000001076782729, createdTime=Wed Oct 05 16:52:36 CST 2022, time=2022-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081263, encodeId=7c541081263ee, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：Received 2021-9-12 Major revision 2021-10-27 Minor revision 2021-12-12 Final accept 2021-12-16 感觉总体来说找到合适的审稿人之后速度还是比较快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d625572154, createdName=wuyan0120, createdTime=Fri Dec 17 20:24:46 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897587, encodeId=a72289e58732, content=审稿4个月，催了三次，最好使用注册时候那个机构邮箱催稿。编辑说很感兴趣，有两个审稿人给了意见，第一个审稿人就夸了夸，第二个人审稿人夸了又给了两条意见。既然夸了就让我过吧求求了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/bc1839eb835e4a28b43c88ba0fd6023b/c54dc7c370634275b2efa25e2af54d04.jpg, createdBy=39735206960, createdName=小汤圆有小心脏, createdTime=Sat Nov 07 17:13:32 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240556, encodeId=cc5212405566a, content=偏重的研究方向：肝癌 经验分享：这个期刊官网上写SCIE Web of science上又写着SCI核心收录，到底算不算核心呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0e08209194, createdName=ms9000002127937775, createdTime=Tue Aug 23 17:49:27 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509261, encodeId=e9f550926139, content=18号刚投出去，期待有个好结果。这个杂志有2个特殊要求：1是要提供官方的邮箱，如edu.cn为结尾的邮箱；2是最好推介不少于3个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcb798907, createdName=bowen, createdTime=Tue Jan 20 21:07:00 CST 2015, time=2015-01-20, status=1, ipAttribution=)]

2020-11-07 小汤圆有小心脏

审稿4个月，催了三次，最好使用注册时候那个机构邮箱催稿。编辑说很感兴趣，有两个审稿人给了意见，第一个审稿人就夸了夸，第二个人审稿人夸了又给了两条意见。既然夸了就让我过吧求求了……

102 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2138227, encodeId=fa1c213822ef2, content=请问这个杂志审稿分几个状态？现在状态是under review，是已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74fc8710249, createdName=ms5000000086594818, createdTime=Sun May 21 20:06:58 CST 2023, time=2023-05-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2118366, encodeId=37bb211836614, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生物标志物;biomarker 经验分享：Received 2023-1-6 Minor revision 2023-3-4 Final accept 2023-3-9 综述文章，审稿人很友好 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIQMh5jMlvAibkVyDXOqwvbsicXibGz4JKG4vvKy81kYq8jSFxGOWAlFqFMWvbOFqt64ibxIUWFTicLeCw/132, createdBy=c12c1661090, createdName=m414297222, createdTime=Thu Mar 09 00:21:48 CST 2023, time=2023-03-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2113050, encodeId=4bbd2113050f5, content=大家最近有投稿吗？多久给回复呢，已经一个月了还在审稿中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Sat Feb 04 21:00:44 CST 2023, time=2023-02-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2094070, encodeId=b7d720940e0cb, content=投了之后多久才会改变状态啊，已经投了一个星期了，还是received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72028228946, createdName=ms4000001076782729, createdTime=Sun Oct 16 16:32:02 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102810, encodeId=bedc21028102f, content=有人有这个期刊的word模板么？能不能发我一下，求助，官网没看到。谢谢了。1225470737*******, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1828451162, createdName=ms6000000080545536, createdTime=Sat Nov 26 21:07:13 CST 2022, time=2022-11-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2091929, encodeId=505020919297d, content=请问下该杂志对创新要求高吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72028228946, createdName=ms4000001076782729, createdTime=Wed Oct 05 16:52:36 CST 2022, time=2022-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081263, encodeId=7c541081263ee, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：Received 2021-9-12 Major revision 2021-10-27 Minor revision 2021-12-12 Final accept 2021-12-16 感觉总体来说找到合适的审稿人之后速度还是比较快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d625572154, createdName=wuyan0120, createdTime=Fri Dec 17 20:24:46 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897587, encodeId=a72289e58732, content=审稿4个月，催了三次，最好使用注册时候那个机构邮箱催稿。编辑说很感兴趣，有两个审稿人给了意见，第一个审稿人就夸了夸，第二个人审稿人夸了又给了两条意见。既然夸了就让我过吧求求了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/bc1839eb835e4a28b43c88ba0fd6023b/c54dc7c370634275b2efa25e2af54d04.jpg, createdBy=39735206960, createdName=小汤圆有小心脏, createdTime=Sat Nov 07 17:13:32 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240556, encodeId=cc5212405566a, content=偏重的研究方向：肝癌 经验分享：这个期刊官网上写SCIE Web of science上又写着SCI核心收录，到底算不算核心呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0e08209194, createdName=ms9000002127937775, createdTime=Tue Aug 23 17:49:27 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509261, encodeId=e9f550926139, content=18号刚投出去，期待有个好结果。这个杂志有2个特殊要求：1是要提供官方的邮箱，如edu.cn为结尾的邮箱；2是最好推介不少于3个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcb798907, createdName=bowen, createdTime=Tue Jan 20 21:07:00 CST 2015, time=2015-01-20, status=1, ipAttribution=)]

2022-08-23 ms9000002127937775

偏重的研究方向：肝癌
经验分享：这个期刊官网上写SCIE Web of science上又写着SCI核心收录，到底算不算核心呢？

43 0

[GetPortalCommentsPageByObjectIdResponse(id=2138227, encodeId=fa1c213822ef2, content=请问这个杂志审稿分几个状态？现在状态是under review，是已经送审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74fc8710249, createdName=ms5000000086594818, createdTime=Sun May 21 20:06:58 CST 2023, time=2023-05-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2118366, encodeId=37bb211836614, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生物标志物;biomarker 经验分享：Received 2023-1-6 Minor revision 2023-3-4 Final accept 2023-3-9 综述文章，审稿人很友好 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIQMh5jMlvAibkVyDXOqwvbsicXibGz4JKG4vvKy81kYq8jSFxGOWAlFqFMWvbOFqt64ibxIUWFTicLeCw/132, createdBy=c12c1661090, createdName=m414297222, createdTime=Thu Mar 09 00:21:48 CST 2023, time=2023-03-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2113050, encodeId=4bbd2113050f5, content=大家最近有投稿吗？多久给回复呢，已经一个月了还在审稿中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Sat Feb 04 21:00:44 CST 2023, time=2023-02-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2094070, encodeId=b7d720940e0cb, content=投了之后多久才会改变状态啊，已经投了一个星期了，还是received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72028228946, createdName=ms4000001076782729, createdTime=Sun Oct 16 16:32:02 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102810, encodeId=bedc21028102f, content=有人有这个期刊的word模板么？能不能发我一下，求助，官网没看到。谢谢了。1225470737*******, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1828451162, createdName=ms6000000080545536, createdTime=Sat Nov 26 21:07:13 CST 2022, time=2022-11-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2091929, encodeId=505020919297d, content=请问下该杂志对创新要求高吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72028228946, createdName=ms4000001076782729, createdTime=Wed Oct 05 16:52:36 CST 2022, time=2022-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081263, encodeId=7c541081263ee, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：Received 2021-9-12 Major revision 2021-10-27 Minor revision 2021-12-12 Final accept 2021-12-16 感觉总体来说找到合适的审稿人之后速度还是比较快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6d625572154, createdName=wuyan0120, createdTime=Fri Dec 17 20:24:46 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897587, encodeId=a72289e58732, content=审稿4个月，催了三次，最好使用注册时候那个机构邮箱催稿。编辑说很感兴趣，有两个审稿人给了意见，第一个审稿人就夸了夸，第二个人审稿人夸了又给了两条意见。既然夸了就让我过吧求求了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200708/bc1839eb835e4a28b43c88ba0fd6023b/c54dc7c370634275b2efa25e2af54d04.jpg, createdBy=39735206960, createdName=小汤圆有小心脏, createdTime=Sat Nov 07 17:13:32 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240556, encodeId=cc5212405566a, content=偏重的研究方向：肝癌 经验分享：这个期刊官网上写SCIE Web of science上又写着SCI核心收录，到底算不算核心呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0e08209194, createdName=ms9000002127937775, createdTime=Tue Aug 23 17:49:27 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509261, encodeId=e9f550926139, content=18号刚投出去，期待有个好结果。这个杂志有2个特殊要求：1是要提供官方的邮箱，如edu.cn为结尾的邮箱；2是最好推介不少于3个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcb798907, createdName=bowen, createdTime=Tue Jan 20 21:07:00 CST 2015, time=2015-01-20, status=1, ipAttribution=)]

2015-01-20 bowen

18号刚投出去，期待有个好结果。这个杂志有2个特殊要求：1是要提供官方的邮箱，如edu.cn为结尾的邮箱；2是最好推介不少于3个审稿人。

217 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务